Home > Boards > US OTC > Biotechs >

Falcon Technologies Inc. (FLCN)

FLCN RSS Feed
Add FLCN Price Alert      Hide Sticky   Hide Intro
Moderator: Taurus69, TKane, PhenixBleu
Search This Board: 
Last Post: 10/21/2019 8:12:12 PM - Followers: 14 - Board type: Free - Posts Today: 0

 



NO KNOWN REVENUE - INADEQUATE DISCLOSURE ON OTC MARKETS - NO KNOWN PRODUCTS - HEAVY DEBT -  EXPECT DILUTION - OTC SHELL RISK FLAG


Eco-Growth Strategies, a Wyoming Corporation

WYOMING REGISTRATION

Falcon Technologies (FLCN) is an Inactive Oregon Corporation. 
Delgado let FLCN go dormant to allow the California Statute of Limitations on debt to run.
He then did a flash
reinstatement of FLCN in Oregon to redomicile to Wyoming on February 11, 2019.

CORPORATE ADDRESS IS A VIRTUAL OFFICE IN NEW YORK AS WELL AS DELGADO'S SECURITY LAWYERS OFFICE

90 Broad Street, 2nd FL
New York, NY 10004

 


Warning! 

This company has posted limited financial disclosure through the OTC Disclosure & News Service
or is late in their filing obligations with the SEC.


ACCORDING TO THE 2018 ANNUAL REPORT, WILLIAM J. DELGADO  IS THE SOLE BENEFICIAL SHAREHOLDER
THE ANNUAL REPORT HAS NO REFERENCE TO FUTURE PLANS EVEN THOUGH IT WAS UPLOADED 02/27/19, WELL AFTER THE COMPANY WAS REDOMICILED
TO WYOMING ON FEBRUARY 11, 2019 UNDER THE NAME ECO-GROWTH STRATEGIES.  THE WYOMING ARTICLES OF INCORPORATION DO NOT NAME DELGADO.
THE WYOMING ARTICLES CONTAIN AN AUTHORIZED SHARE COUNT OF 500,000,000 AND PREFERRED SHARE COUNT OF 10,000,000. 

 

OTC MARKETS SECURITY DETAILS

A/S 100,000,000 as of 02/26/2019
O/S 19,531,847 as of 12/31/2018

FLOAT 5,086,101 as of 03/27/2019
Why are the counts not updated on the same day?

WYOMING SECRETARY OF STATE SECURITY DETAILS

A/S 500,000,000 as of 02/11/2019


 

STOCK TRADES BEGAN THE DAY OF THE WYOMING FILING, FEBRUARY 11, 2019,
AND CONTINUED UNTIL THE DAY BEFORE THE DELINQUENT FLCN FILINGS WERE UPLOADED TO OTC MARKETS. 
THAT'S 11 DAYS OF TRADING WITHOUT PUBLIC DISCLOSURE OR NEWS FROM WILLIAM J. DELGADO.
THE SHIFT TO ECO-GROWTH STRATEGIES WAS NOT PUBLIC KNOWLEDGE. THE WYOMING FILING DIDN'T NAME FLCN OR DELGADO.
HOW DID THE EARLY TRADERS LEARN ABOUT THE PENDING TRANSITION?

 
 

2018 ANNUAL REPORT SHOWS
 

ASSETS 1,200
LIABILITIES 1,600,000

NOTES FROM THE 2018 ANNUAL REPORT

(1) All income related assets (receivables, notes, costs in excess of billings) have been zeroed out. There
has been no activity in the last several years in these accounts or the attempts to collect said assets.

(2) All liability accounts have been adjusted accordingly. All of the liabilities, except for notes due to related party,
have exceeded the statute of limitations for the State of California, where such liabilities were incurred.

(3) William J. Delgado, CEO and sole director, on behalf of the shareholders of Falcon Technologies, Inc.,
initiated legal action against three of the former officers and directors of FLCN in 2009. Although legal
counsel was working on a contingency fee arrangement and the probability of success was positive, it was
determined by the company and legal counsel that collectability would be difficult, if not impossible.
The decision not to continue was made mutually by the company and the company’s legal counsel.


The above section will be managed by Moderator PhenixBleu. 
Please review the reasons why posts get deleted.  It's all about the terms each member agrees to upon registering their accounts.

Deletion of Posts
 

=============================================================================================================================================================================



IH USERS: BELOW IS ACTUAL NEWS AND UNBIASED INFO ON FALCON TECHNOLOGIES



BREAKING NEWS FOR FALCON TECHNOLOGIES, INC. IS OUT !!!!!



***July 24, 2019*** FLCN Filing Trademark Application for Dietary Supplement for the Pet Market with Plans to Launch CBD Brand for Pets
 

https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Filing-of-a-Trademark-Application-for-a-Dietary-Supplement-for-the-Pet-Market-with-Pla?id=235021 

 
Wednesday, July 24, 2019 7:00 AM

SACRAMENTO, CA / ACCESSWIRE / July 24, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focused on the marketing, sale, and distribution of CBD products and other products derived from industrial hemp announced today that it has filed a trademark application with the United States Patent and Trademark Office for a new dietary supplement for pets. The trademark has been filed as a result of Falcon’s ongoing efforts to work with professionals to launch quality CBD products.

According to the American Pet Products Association, pet owners spent more than $72 billion on their pets in 2018. As the global pet care market continues its meteoric rise, all reports point to the fact that CBD-infused pet products will represent the highest compound annual growth rate (CAGR) in the global market for pet products.

The market for human CBD products has been growing for about a decade. However, the market for pet products infused with CBD is just beginning to grow. Sixty-eight percent of all U.S. households have at least 1 pet which equates into 85 million families. That number is up from 56 percent of all households in 1986.

CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.

William Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, “The trademark application should give our shareholders and all investors a hint about what our plans are. We are fully committed to working with top professionals to build brands that represent honesty, quality, reliability, integrity and sustainability. Going forward, we are committed to the pet market as well as the human market to build successful CBD brands.”

Mr. Delgado added, “We will be announcing further details about the trademark application and our plans for the CBD pet market shortly.”

About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.

CBD Disclaimer

The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

William J. Delgado
(775) 443-4740
djwllc@hotmail.com

SOURCE: Falcon Technologies


***July 22, 2019*** Falcon Technologies Announces the Company Has Achieved Pink Sheet Current Information Status at OTC Markets
 

https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Company-Has-Achieved-Pink-Sheet-Current-Information-Status-at-OTC-Markets?id=234812


Falcon Technologies Announces the Company Has Achieved Pink Sheet Current Information Status at OTC Markets

Monday, July 22, 2019 9:00 AM

SACRAMENTO, CA / ACCESSWIRE / July 22, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focused on the marketing, sale, and distribution of CBD products and other products derived from industrial hemp, announced today it has achieved Pink Sheet Current Information Status at OTC Markets.

The Company also announced it expects to have CBD products available for sale in August 2019.

William Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, “Over the past few months, Falcon has worked extremely hard to complete and post all our financial statements at OTC markets and to provide all additional paperwork to OTC Markets to achieve Current Information Pink Sheet status.”

Mr. Delgado added, “We expect to have CBD products available for sale in August 2019. Initially, we expected to have products available at an earlier date. However, there have been certain very positive developments that are causing the delay, but these developments are very beneficial for all our shareholders. It is our goal to offer reliable, branded products for consumers and we are working hard to achieve that goal. We expect to deliver additional news to shareholders shortly.”

About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.

CBD Disclaimer

The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: William J. Delgado
(775) 443-4740
djwllc@hotmail.com

SOURCE: Falcon Technologies, Inc.

 

 

***APRIL 25, 2019*** Falcon Technologies (Ticker: FLCN) Announces the Filing of a Provisional Patent Application for CBD Formulations to Treat Ulcers


SACRAMENTO, CA / ACCESSWIRE / April 25, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office. The invention is titled "CBD Formulations to Treat Peptic and Gastrointestinal Ulcers".

The pharmaceutical and OTC drug markets to treat ulcers is one of the largest medical markets in the United States. Approximately 4% of all adult Americans suffer from peptic (also called gastrointestinal) ulcers. Peptic ulcers can occur in the stomach, the intestines and even parts of the esophagus. This invention covers all non-cancerous ulcers that occur in the stomach, the intestines and even parts of the esophagus. The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) (Advil, Aleve, others).

The provisional patent application number is 62838236. At this time, Falcon will not reveal any details about the provisional patent application except for the fact that the formulation contains CBD and an off-patent ingredient from one of the most well known and well-documented healthcare products in the entire world. The purpose and goal of the patent is to secure patent protection now to operate in what is another multi-billion-dollar market.

This provisional patent application follows Falcon's recent provisional patent application to treat acne with certain CBD formulations. The latest provisional patent application continues Falcon's strategy to gain advantages over potential competition. These advantages may be marketing and sales advantages or formulation advantages such as the one covered by this provisional patent application.

William J. Delgado, Chairman and Chief Executive Officer of Falcon Technologies stated, "We are ecstatic that we can deliver this great news to our shareholders. We are working diligently to gain an advantage over the other companies currently selling CBD products and this second provisional patent application is another example of the progress we are making with our overall corporate strategy."

CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.

About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.

CBD Disclaimer

The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: William J. Delgado
(775) 443-4740
djwllc@hotmail.com

SOURCE: Falcon Technologies

U201904260000




***MARCH 21, 2019*** Provisional Patent Protection was filed for by FLCN for "CBD Formulations to Treat Acne" Patent

 
Falcon Technologies Announces the Filing of a Provisional Patent Application Titled ''CBD Formulations to Treat Acne'' 

SACRAMENTO, CA / ACCESSWIRE / March 21, 
2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office. The invention is titled ''CBD Formulations to Treat Acne''. As previously announced, the company expects to have its first products available for sale on or before April 30, 2019. 

Acne is the most common skin condition in the United States. More than 50 million Americans suffer from acne. Acne is a medical problem defined by a persistent and constant inflammation and infection of the sebaceous glands in the skin. Often, acne coexists with other medical problems. Although some medications work for a percentage of people, a large percentage of all acne sufferers suffer from acne for an average period of 5 years or more with little or no relief. A person who suffers from acne can also suffer from self-esteem issues and even depression. No other skin condition affects more Americans or more people in the world than acne. 

The provisional patent application number is 62821332. At this time, Falcon will not reveal any details about the provisional patent application except for the fact that the formulation contains CBD and the purpose and goal of the patent is to secure patent protection now to operate in what is a multi-billion-dollar market. 

William J. Delgado, Chairman and Chief Executive Officer of Falcon Technologies, Inc. stated, ''One of our recently stated goals is to gain a competitive advantage in the CBD market and this provisional patent application is the start of a multi-pronged strategy to do just that.'' 

The Company's short-term goals which are in the process of being fulfilled are the following: 

1.Complete supply chain agreements.
2.Complete branding message. 
3.Finalize initial marketing plans. 
4.Complete initial distribution agreements. 
5.Complete licensing and partnership agreements. 
6.Complete online messaging and presence. 
7.Launch social media campaigns. 
8.Complete competitive advantage initiatives which are of paramount importance to our business plan. 

CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties. 

About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) 

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019. 

CBD Disclaimer 

The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice. 

SAFE HARBOR ACT 

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise. 

Contact: 

William J. Delgado 

djwllc@hotmail.com

775-443-4740

SOURCE: Falcon Technologies
 
 
***MARCH 18, 2019*** Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) Announces Entry into the CBD Market 


SACRAMENTO, CA / ACCESSWIRE / March 18,2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today its immediate entry into the CBD market. The company's short-term focus will be on the marketing and sale of topical, high strength applications of CBD. Shortly thereafter, the company also plans on launching a high strength CBD hemp oil. The company expects to have its first products available for sale on or before April 30, 2019.

The Company's short-term goals which are in the process of being fulfilled are the following:

Complete supply chain agreements.
Complete branding message.
Finalize initial marketing plans.
Complete initial distribution agreements.
Complete licensing and partnership agreements.
Complete online messaging and presence.
Launch social media campaigns.
Complete competitive advantage initiatives which are of paramount importance to our business plan.


CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.


William J. Delgado, Chairman and Chief Executive Officer of Eco-Growth Strategies, Inc. commented, "The market for CBD is one of the most rapid growth markets in the United States. Our plan is to offer moderately priced CBD products. All of our products and CBD will be sourced from U.S. based farms after we perform site visits to ensure the quality of the product that we will market and sell to the public."

Mr. Delgado added, "We are building what we believe will be a significant competitive advantage over the other CBD product companies and we reveal our position to all our shareholders shortly."


About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)


Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.


CBD Disclaimer


The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Actrequires this notice.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


Contact: William J. Delgado

djwllc@hotmail.com

75-443-4740

SOURCE: Falcon Technologies


 

FALCON TECHNOLOGIES - A CBD PRODUCT COMPANY - FOCUSED ON THE FUTURE

FALCON TECHNOLOGIES, INC. IS A PUBLICLY-HELD OTC COMPANY TRADING UNDER STOCK TICKER: FLCN

CONTACT US: 6220 MAIN AVE #2 ORANGEVILLE CA 95662; PHONE 916-838-8833; EMAIL djwllc@hotmail.com







Falcon Technologies, Inc. a/k/a Eco-Growth Strategies, Inc. is a nutraceutical company developing a range of CBD products: Company Profile: https://www.otcmarkets.com/stock/FLCN/profile

4/25/2019 News Out: 
Falcon Technologies (Ticker Symbol: FLCN) Announces the Filing of a Provisional Patent Application for CBD Formulations to Treat UlcersPress Release

Check it out:  https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Filing-of-a-Provisional-Patent-Application-for-CBD-Formulations-to-Treat-Ulcers?id=225942


3/21/2019 News Out:https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Filing-of-a-Provisional-Patent-Application-Titled-CBD-Formulations-to-Treat-Acne?id=222179


3/18/2019 News Outhttps://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Inc-aka-Eco-Growth-Strategies-Inc-Announces-Entry-into-the-CBD-Market?id=221731




Further updates on CBD products entering the market place in 2019 will be posted as released! Falcon Technologies, INc., a CBD company, is looking forward to future growth and value!

 



FALCON TECHNOLOGIES, INC. - OTC TICKER SYMBOL: FLCN


 


The IH Rules of the Road (IH Source Documents) covering User Posting on IH Stock Boards

IH Terms of Service (TOS) on users and posts:  https://investorshub.advfn.com/boards/terms.aspx

IH Handbook contains rules regarding posting:   http://ihwiki.advfn.com/index.php?title=Handbook



Here's to a pleasant experience exploring and using the FLCN (Falcon Technologies) Stock Board! Please contact IH Admin with any negative experiences. Thank you.






.

FLCN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#878  Sticky Note $flcn has landed $.14 Taurus69 09/17/19 01:28:12 AM
#131  Sticky Note Forte Capital Partners LLC vs. William J. Delgado PhenixBleu 03/15/19 10:47:36 AM
#893   FLCN in consolidation mode again. Another buying opportunity. TKane 10/21/19 08:12:12 PM
#892   The valuations are the result of pumps on PhenixBleu 10/18/19 09:48:49 AM
#891   Delgado aligns himself with the shareholders. The thousands flight director 10/17/19 11:40:47 PM
#890   You nailed it as you always do. I've PhenixBleu 10/17/19 09:58:29 PM
#889   Guess he is worth it. GDSI was $250K flight director 10/17/19 09:17:15 PM
#888   Maybe one day Delgado will make a single MrBlackLungs 10/17/19 04:14:04 PM
#887   Would be nice to see something this week.... Anything AfternoonDelight 10/15/19 09:36:45 AM
#886   $flcn $.065 Delgado’s debacle Taurus69 10/09/19 11:02:45 PM
#885   FLCN has previously hit 0.3-0.6 from this point. TKane 10/04/19 11:41:35 AM
#884   $flcn $.095 in 13k volume Taurus69 09/30/19 04:24:36 AM
#883   FLCN continues to consolidate. Waiting, waiting...then boom. GL TKane 09/27/19 03:37:24 PM
#882   More buying volume coming in....can we reach 100k hockeypond 09/25/19 12:17:01 PM
#881   Sweet. FLCN consolidation continues. Slowly, but surely. TKane 09/24/19 04:39:38 PM
#879   FLCN consolidation time. Get ready for the bounce. TKane 09/17/19 04:21:19 PM
#878   $flcn has landed $.14 Taurus69 09/17/19 01:28:12 AM
#877   FLCN has some spring to it. It happened TKane 09/15/19 07:19:12 PM
#876   Except you can't sell. Sell orders, even below JoshTaeger 09/05/19 03:39:01 PM
#875   Why not? Makes folks $$$. Okay with me. TKane 09/04/19 08:32:49 PM
#874   Delgado always issues sloppy fins. Why should anyone PhenixBleu 09/04/19 11:41:25 AM
#873   Looks like they filed an amended disclosure. Guess flight director 09/04/19 11:36:14 AM
#872   FLCN ace, baby! Fly high and them some, FLCN! TKane 09/04/19 11:12:38 AM
#871   $flcn $.10 Delgado’s debacle Taurus69 09/04/19 03:47:17 AM
#870   Read the Disclosure Statement for Q2...lol. They aren't PhenixBleu 09/03/19 04:05:13 PM
#869   Happy Labor Day! FLCN resting before moving again. TKane 09/02/19 11:02:42 AM
#868   Disagree. FLCN ran to near .50 this spring. TKane 09/01/19 02:58:55 PM
#867   Nobody wants it, even at 24 cents. I JoshTaeger 08/28/19 10:18:49 AM
#866   I'll be happy to flip it while it JoshTaeger 08/26/19 09:45:41 AM
#865   More ping-ponging with FLCN. Its sector hasn't been TKane 08/23/19 04:46:19 PM
#864   FLCN holding up well. Drops, then back up. TKane 08/23/19 01:20:40 PM
#863   It's great to see FLCN is Pink Current! TKane 08/20/19 12:34:41 AM
#862   Increased access to CBD pet products rocks! TKane 08/19/19 02:15:39 PM
#861   $flcn $.25 Taurus69 08/05/19 07:00:52 PM
#860   Looks like the insiders and loyalists aren't buying PhenixBleu 07/24/19 10:58:44 AM
#859   Delgado doesn't want us to know how many PhenixBleu 07/24/19 09:49:27 AM
#858   Trademark applications are not impressive news events. The PhenixBleu 07/24/19 09:46:01 AM
#857   $FLCN Falcon Technologies Announces the Filing of a deri21 07/24/19 07:34:40 AM
#856   Yeah he did. Phenomenal day for SHMP AfternoonDelight 07/22/19 05:10:30 PM
#855   It appears that Mr. Delgado had a fine eqinvestor 07/22/19 04:28:10 PM
#854   Mine say twice that...LOL! Roll FLCN Roll! AfternoonDelight 07/22/19 04:11:18 PM
#853   That happens when insiders pump their own stock. PhenixBleu 07/22/19 01:35:48 PM
#852   BTW, my quote says up 47 percent !! eqinvestor 07/22/19 12:39:31 PM
#850   LOL! That's an achievement to Delegado. To PhenixBleu 07/22/19 11:04:50 AM
#849   $FLCN Falcon Technologies Announces the Company Has Achieved deri21 07/22/19 09:09:14 AM
#848   It's quite simple to understand when one clicks PhenixBleu 07/19/19 12:12:38 PM
#847   Sorry, OTC Markets says its current information. Don’t eqinvestor 07/19/19 11:21:44 AM
#846   When is your boss going to update their PhenixBleu 07/19/19 10:32:29 AM
#845   They are back and we are current information. eqinvestor 07/19/19 10:10:53 AM
#844   $flcn maciora and Delgado are frauds. Debacle. Taurus69 07/18/19 06:35:11 PM
#843   Any idea on what's happening with the FLCN hockeypond 07/18/19 11:30:54 AM
#842   Looks like we have undeniable proof of fluff PhenixBleu 07/17/19 08:20:22 AM
PostSubject